circPRKCE靶向TGF-β/Smad7通路抑制EMT参与落新妇苷防治放射性肺纤维化的作用及机制研究
批准号:
82060019
项目类别:
地区科学基金项目
资助金额:
34.0 万元
负责人:
胡凯
依托单位:
学科分类:
间质性肺疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
胡凯
中文摘要
放射性肺纤维化(RIPF)是放疗过程中常见的并发症,发病机制尚未完全阐明。我们前期发现肿节风提取物可通过抑制TGF-β/Smads信号通路介导的上皮间质转化进而防治RIPF。落新妇苷是肿节风提取物主要的活性成分之一,具有强抗炎抗氧化性,通过二代测序和生信分析研究落新妇苷处理后RIPF小鼠肺组织中circRNA,miRNA及mRNA表达谱的变化,发现circPRKCE、miR-15b-5p和Smad7之间可能存在竞争性内源RNA机制,落新妇苷可能通过调节circPRKCE靶向TGF-β/Smad7通路抑制上皮间质转化进而防治RIPF。本课题拟在此基础上通过体内外模型,运用RIP、双荧光素酶报告实验、腺相关病毒载体及挽救实验等研究手段,进一步揭示落新妇苷对RIPF的防护作用及分子机制,从非编码RNA水平为它防治RIPF提供新依据。
英文摘要
Radiation-induced pulmonary fibrosis (RIPF) is a common complication during radiotherapy, and the pathogenesis has not been fully elucidated. We previously discovered that Sarcandra glabra. Extract can prevent RIPF via EMT inhibition mediated by the TGF-β/Smads signaling pathway. Astilbin, one of the main active ingredients of Sarcandra glabra. Extract, has strong anti-inflammatory and antioxidant properties. The changes of circRNA, miRNA and mRNA expression profiles in lung tissues of RIPF mouse model with Astilbin treatment were studied by next-generation sequencing and bioinformatic analyses. It was found that there may be a competing endogenous RNA between circPRKCE, miR-15b-5p and Smad7, while Astilbin may prevent RIPF via EMT inhibition mediated by circPRKCE-targeted TGF-β/Smad7 signaling Pathway. On the above premises, we aim to investigate the effects and molecular mechanisms of Astilbin in prevent RIPF by a series of experiments, including RIP, dual-luciferase reporting experiment, adeno-associated virus vector and rescue experiment. We hope it can afford new basis for the anti-RIPF effects of Astilbin from the molecular perspective of circRNA.
放射诱导性肺纤维化 (RIPF) 是胸部肿瘤放射治疗所致的一个严重并发症,目前尚无有效的预防或治疗方法。既往有文献报道中药落新妇苷具有减轻包括肺纤维化在内的器官纤维化作用。本研究探讨了中药黄酮类化合物落新妇苷 (AST) 对 RIPF 的保护作用。我们在体外和体内评估了 AST 对放射诱导的上皮间质转化 (EMT) 和肺纤维化的影响。研究表明,落新妇苷可抑制放射诱导的 EMT,从而减少小鼠肺上皮细胞的肺纤维化。高通量测序显示,AST 上调与纤维化相关的非编码 RNA circPRKCE。RNA-FISH 和功能丧失实验证实,circPRKCE 通过 ceRNA 机制发挥作用,与 miR-15b-5p 结合,随后抑制 smad7 表达。我们的研究结果表明,AST 通过调节 circPRKCE/miR-15b-5p/smad7 轴来缓解 RIPF,从而抑制 EMT。这些结果为开发 RIPF 的预防和治疗药物开辟了新的可能性,并揭示了所涉及的分子机制。
国内基金
海外基金